Where to source glp-1 for medspas?
US$ 29.19
soul trial oral semaglutide cardiovascular outcomes results 2024 2025 Reduces CV Events in T2DM โ (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine ๐งช T2DM + ASCVD/CKD ๐ Oral semaglutide 14 mg vs placebo ๐ Clinical Effectiveness and Safety of
Description
If you don't like injections, there's also a tablet version called "Rybelsus" that you can take every day
Rather than viewing pharmacotherapy as a last resort for treatment-resistant individuals, GLP-1RAs could normalize the use of medication as a preventative measure much like statins for cardiovascular disease or metformin for prediabetes
I like being recognized as such
contraindication screening and interaction checks are integral to study design
No follow-up after your prescription ships
